1. Major results from the first plasma campaign of the Wendelstein 7-X stellarator. (27th July 2017) Authors: Wolf, R.C.; Ali, A.; Alonso, A.; Baldzuhn, J.; Beidler, C.; Beurskens, M.; Biedermann, C.; Bosch, H.-S.; Bozhenkov, S.; Brakel, R.; Dinklage, A.; Feng, Y.; Fuchert, G.; Geiger, J.; Grulke, O.; Helander, P.; Hirsch, M.; Höfel, U.; Jakubowski, M.; Knauer, J. Journal: Nuclear fusion Issue: Volume 57:Number 10(2017:Oct.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Major results from the first plasma campaign of the Wendelstein 7-X stellarator. (27th July 2017) Authors: Wolf, R.C.; Ali, A.; Alonso, A.; Baldzuhn, J.; Beidler, C.; Beurskens, M.; Biedermann, C.; Bosch, H.-S.; Bozhenkov, S.; Brakel, R.; Dinklage, A.; Feng, Y.; Fuchert, G.; Geiger, J.; Grulke, O.; Helander, P.; Hirsch, M.; Höfel, U.; Jakubowski, M.; Knauer, J. Journal: Nuclear fusion Issue: Volume 57:Number 10(2017:Oct.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Overall survival results from the phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma (METEOR). (February 2017) Authors: Schmidinger, M.; Motzer, R.J.; Powles, T.; Escudier, B.; Tannir, N.M.; Mainwaring, P.N.; Rini, B.I.; Hammers, H.J.; Donscov, F.; Roth, B.; Peltola, K.; Lee, J.L.; Heng, D.Y.C.; Aftab, D.T.; Hessel, C.; Scheffold, C.; Schwab, G.; Pal, S.; Hutson, T.E.; Choueiri, T.K. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Professor Francis Rendel Erskine Crossley, Founder of IFToMM. (July 2017) Authors: Rao, J.S.; Roth, B. Journal: Mechanism and machine theory Issue: Volume 113(2017:Jul.) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗